Martha Geoffrey
Chairman and CEO
Martha Geoffrey has filed 6 SEC Form 4 filings (7 transaction rows) across 2 companies, including MDT, NEE, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Oct 16, 2026.
On the most recent filing, Martha Geoffrey is listed as Chairman and CEO at Medtronic plc. Inside the rolling window, Martha Geoffrey reported no open-market purchases and 1 open-market sale totaling $4.8M in MDT.
Companies traded
Other insiders at MDT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.8M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Martha Geoffrey made?
Martha Geoffrey has filed 6 SEC Form 4 filings (7 transaction rows) across 2 companies, including MDT, NEE since 2025.
Which companies does Martha Geoffrey trade?
Martha Geoffrey has filed SEC Form 4 disclosures for 2 companies, including MDT, NEE.
When was Martha Geoffrey's most recent SEC Form 4 filing?
Martha Geoffrey's most recent SEC Form 4 filing on Tracefour is dated Oct 16, 2026.
What is Martha Geoffrey's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Martha Geoffrey is listed as Chairman and CEO.
What is Martha Geoffrey's total buy and sell value in the current window?
Inside the rolling retention window, Martha Geoffrey bought $0 and sold $4.8M based on SEC Form 4 filings.
What was Martha Geoffrey's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 50,000 MDT shares on 2026-10-15, worth $4.8M, per SEC Form 4 filings.